Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Stock

Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversing

admin by admin
July 8, 2025
in Stock
0
Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversing
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Shares of Moderna surged 9.5% on Tuesday to $32.75 in a notable reversal of recent bearish sentiment, buoyed by legal developments and renewed investor focus on the company’s potential vaccine pipeline.

The uptick follows a turbulent period for the pharmaceutical firm, which has seen its stock tumble more than 80% over the past year.

On Monday, a coalition of major medical organizations filed a lawsuit against US Health Secretary Robert F. Kennedy Jr. and the Department of Health and Human Services, challenging recent decisions to remove healthy children and pregnant women from the COVID-19 vaccine schedule.

The plaintiffs argued the changes represent a clear threat to public health and demanded the court declare the moves unlawful.

The lawsuit, led by Richard H. Hughes IV—a vaccine law expert from George Washington University—accuses Kennedy of attempting to dismantle public confidence in vaccines.

“The secretary’s intentions are clear,” said Hughes. “He aims to destroy vaccines.”

The plaintiffs include the American Public Health Association, the American Academy of Pediatrics, and other top health bodies.

Analyst sees gain as “reversal of peak negative investor sentiment”

B. Riley Securities analyst Mayank Mamtani said Moderna’s share movement likely reflects “a reversal of peak negative investor sentiment,” pointing to the recent lawsuit and upcoming vaccine advisory committee meetings as potential short-term catalysts.

The news may have helped rebalance sentiment in a market that had heavily shorted the stock.

Other vaccine makers also posted gains, with Pfizer rising 1.6% and Novavax climbing 6.7%.

The latter benefited from recent late-stage study results tied to its COVID-influenza combination and standalone flu vaccines, Mamtani said.

Why is MRNA struggling?

Despite the day’s gains, Moderna’s outlook remains difficult.

The company is still down 22% year-to-date and 72% over the past 12 months.

Investor confidence was shaken last year after Moderna announced weaker vaccine sales in Europe, attributed to a renegotiated contract between the EU and Pfizer-BioNTech.

The news led to a steep sell-off following the company’s second-quarter earnings.

Financially, Moderna’s revenue has dropped sharply, from $18.9 billion in 2022 to $3.1 billion over the past year, an 83% decline.

Sales are forecast to drop further to around $2.1 billion in 2025 as demand for COVID-19 vaccines continues to wane and the company adjusts to a seasonal vaccine model.

Short interest remains high despite the recent bounce.

As of mid-June, 18.6% of Moderna’s float was sold short, making it the second most-shorted stock in the S&P 500, down only slightly from May’s peak levels.

In January, Moderna cut its 2025 revenue forecast by $1 billion and pushed back its break-even expectations by two years, citing delays in its product development pipeline.

The post Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversing appeared first on Invezz


Previous Post

Here’s why KOSPI Index rose after tariffs and weak Samsung earnings

Next Post

EU’s US trade deal to help Airbus, BMW, Mercedes-Benz: report

Next Post
EU’s US trade deal to help Airbus, BMW, Mercedes-Benz: report

EU’s US trade deal to help Airbus, BMW, Mercedes-Benz: report

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
Oracle stock at record high: time to take profits or let it run?

Oracle stock at record high: time to take profits or let it run?

July 3, 2025
Bangladesh approves wheat purchase from the US to ease trade tensions

Bangladesh approves wheat purchase from the US to ease trade tensions

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Bangladesh approves wheat purchase from the US to ease trade tensions

Bangladesh approves wheat purchase from the US to ease trade tensions

July 30, 2025
Foxconn eyes $1 trillion AI data centre market with TECO stake

Foxconn eyes $1 trillion AI data centre market with TECO stake

July 30, 2025
Analysis: EU’s ambitious US energy import target faces major hurdles

Analysis: EU’s ambitious US energy import target faces major hurdles

July 30, 2025
Google to invest $6 billion in Andhra Pradesh, India’s largest data centre move yet

Google to invest $6 billion in Andhra Pradesh, India’s largest data centre move yet

July 30, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Bangladesh approves wheat purchase from the US to ease trade tensions

    Bangladesh approves wheat purchase from the US to ease trade tensions

    July 30, 2025
    Foxconn eyes $1 trillion AI data centre market with TECO stake

    Foxconn eyes $1 trillion AI data centre market with TECO stake

    July 30, 2025
    Analysis: EU’s ambitious US energy import target faces major hurdles

    Analysis: EU’s ambitious US energy import target faces major hurdles

    July 30, 2025
    Google to invest $6 billion in Andhra Pradesh, India’s largest data centre move yet

    Google to invest $6 billion in Andhra Pradesh, India’s largest data centre move yet

    July 30, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved